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Mammary carcinomas induced by the administration of 7,12-dimethylbenz(a)anthracene (DMBA)
to young virgin rats arise from undifferentiated terminal ductal structures called terminal end buds
(TEBs). TEBs that normally differentiate into alveolar buds (ABs) and lobules under the influence of
DMBA develop intraductal proliferations which progress to carcinoma. The high susceptibility of
the young virgin rat TEBs to neoplastic transformation is due to its large proliferative compart-
ment, with cells cycling every 10 hr, and to a higher 3H-DMBA uptake. Progressive differentiation of
TEBs into ABs and lobules or their regression to terminal ducts (TDs) is seen with aging. Complete
differentiation of the gland is attained only through pregnancy and lactation. The greater differen-
tiation of the gland is manifested as permanent structural changes, consisting in the disappearance
of TEBs and in a diminution of the number of TDs due to their differentiation into ABs and lobules.
This greater differentiation results in a diminished or total refractoriness of the gland to the carcin-
ogen because ABs and lobules have a lower proliferative compartment and a longer cell cycle than
TEBs and TDs. Cells of parous rats have both in vivo and in vitro a lower DMBA-DNA binding ca-
pacity, a lower DNA synthesis and a greater ability to repair DMBA damaged DNA than cells of
young virgin rats. The more efficient DNA repair capacity of the parous rat mammary gland is dem-
onstrated by the induction of unscheduled DNA synthesis and a removal of DMBA-DNA adducts.
Introduction
Breast cancer is a tumor that arises from a hy-
perplastic growth of the mammary gland epithelium
(1-6). Although the etiologic agent(s) which stimulate
the epithelial growth that eventually evolves into
neoplasia is not yet known, certain common denomi-
nators have been found (Table 1) (7-75). Epidemiolog-
ic observations reveal that mammary carcinomas
occur more frequently in nulliparous than in multi-
parous women (27-29, 47, 76-78), in women having an
early menarche (12-19, 79, 80) and in those whose
first pregnancy occurs after 25 years of age (12-15,
81). Pregnancy before age 18 (11, 12, 81, 82) and late
menarche (79) are related to a lower risk of breast
carcinoma. Just how women are protected by early
pregnancy has been widely discussed, but there is
very little information beyond the fact itself. The
understanding of the mechanism by which early
pregnancy protects women from breast cancer re-
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Table 1. Common denominators in the natural history of
breast carcinoma.
Endocrine or hormone-related factors
Age at menarche, first pregnancy, and menopause
Parity
Androgen and estrogen secretion
Anovulatory cycles
Environmental factors
Geography
Diet
Socioeconomic status
Familial and/or heredity factors
Familial aggregation
Specific antigens
Cerumen type
quires a thorough comprehension of the pathogene-
sis of the disease and how the reproductive history
influences the susceptibility of the mammary gland
to carcinogenesis. Due to sampling and ethical limi-
tations intrinsic to human experimentation, what is
needed is an experimental model for breast tumors
which mimics the most significant aspects of the hu-
man disease. Recent studies (62, 83-86) suggest thatRUSSO ETAL.
mammary carcinomas induced in Sprague-Dawley
rats by 7,12-dimethylbenz(a)anthracene (DMBA) con-
stitutes such a model. DMBA-induced rat mammary
carcinomas are hormone-dependent adenocarcino-
mas histologically similar to human breast tumors
(62, 87,88). Tumor incidence is higher when the car-
cinogen is administered to nulliparous rats (62, 83,
89). Although tumor growth is stimulated by preg-
nancy (88, 90), a full-term pregnancy and lactation
prior to carcinogen administration inhibits tumor
development (83, 85). Therefore, the relationship be-
tween nulliparity and the probability of the female
rat of developing mammary cancer after carcinogen
administration is similar to that observed in human
females.
Other carcinogens such as N-methyl-N-nitroso-
urea (91) and aromatic amine derivatives have also
been used to induce mammary carcinomas (92, 93).
However, the model system most used for the
study of the pathogenesis of the disease as well as
the understanding of the mechanism of susceptibil-
ity is the DMBA-induced mammary carcinoma rat
experimental model. It is likely that the knowledge
gained with this experimental model could also be
applied to mammary cancers induced by other car-
cinogens and ultimately for the understanding of
the human disease.
Induction of Mammary Tumors by
Polycyclic Aromatic Hydrocarbons
(PAH)
Many PAHs are potent carcinogens and muta-
gens that are widely distributed as pollutants in the
environment. Of great significance in breast carcino-
genesis is the finding of Huggins and co-workers (94,
95) that under optimal conditions, intragastric instil-
lation of DMBA or benzo(a)pyrene [B(a)P]) to rats in-
duces mammary cancers. Mammary cancers have
also been detected when PAH are administered by
other means (96, 97); they have also been regarded
FIGURE 1. Postnatal development of the rat mammary gland and site of origin of DMBA-induced mammary carcinoma: (a) ter-
minal end buds at 50 days of age; (b) TEBs differentiated into alveolar buds; (c) alveolar buds differentiated in the small due-
tules of the virginal lobules; (b') intraductal proliferation originated from TEB after DMBA treatment; (c') microtumor.
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as direct-acting carcinogens because microgram
quantities are capable of causing cancer at the site
of administration (98).
Pathogenesis of Rat Mammary Carcinomas
DMBA administration to young virgin rats in-
duces a high incidence of carcinomas. This is due to
the fact that the mammary gland of young virgin
animals is in an early stage of development and is
composed of numerous terminal end buds (TEBs)
which are actively differentiating into alveolar buds
(ABs) (Fig. 1). TEBs (Fig. la) present in the mam-
mary gland at the time of carcinogen administration
are transformed by DMBA, becoming larger due to
intraductal proliferation (IDP) of the lining
epithelium (Fig. lb and Fig. 2). IDPs increase
progressively in size and become confluent, leading
to the formation of microtumors (Fig. lc) which
histologically are adenocarcinomas (62, 87, 99, 100).
Although the differentiation of TEBs into ABs is
inhibited by DMBA treatment, not all the TEBs
present in the mammary gland at the time of
DMBA administration progress to IDPs. Some of
them differentiate into ABs and occasional lobular
development is observed. Those TEBs that are
already differentiated into ABs prior to DMBA
administration do not develop carcinomas. Most of
them either remain unmodified or proliferate
moderately, forming microscopic adenomas, or
undergo dilatation of the lumen, giving rise to
hyperplastic alveolar nodules (HAN) and cysts (Fig.
3). These observations indicate that the carcinogen
alters the normal process of differentiation of the
gland. The carcinogen requires an adequate
FIGURE 2. Schematic representation of the effects of DMBA
on cellular differentiation and proliferation. TEB, terminal
end bud; TD, terminal duct; AB, alveolar bud; ID, in-
traductal proliferation.
structural target that determines the type of lesion
induced depending upon the area of the mammary
gland with which it is in contact. Thus, the more
differentiated the structure at the time of car-
cinogen administration, the more benign and
organized is the lesion which develops (Fig. 3) (101,
102).
Cell of Origin of Mammary Carcinoma
The mammary gland epithelium is composed of
three main cell types, intermediate, dark and myo-
FIGURE 3. Evolution of the lesions induced by DMBA in the TEB and AB of the rat mammary gland.
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epithelial cells, which possess morphological and cell
kinetic properties that allow the differentiation of
one cell type from another (103, 104). These cells are
present in a constant proportion in the various com-
partments, namely TEB, TD, AB and lobules of the
gland (Fig. 4). Following DMBA administration, the
distribution of dark and intermediate cells changes
in the TD and TEB, with a significant increase in
the number of intermediate cells at the expense of
dark cells. Myoepithelial cells (MC) are unaffected.
The proportion of intermediate cells continues to in-
crease with tumor age and in the well-developed tu-
mor they represent nearly 90% of the total number
of cells, while dark cells are reduced to approxi-
mately 10%, and MC become undistinguishable
(Fig. 4). The intermediate cell type seems to be the
site of neoplastic proliferation, as suggested by its
higher DNA-LI after DMBA administration, which
has been shown to depress the DNA-LI of other cell
types, resulting in a progressive increase of inter-
mediate cells during the carcinogenetic process.
Mammary Gland Differentiation as
a Determinant of Susceptibility to
Carcinogenesis
Differentiation is considered to be the process by
which a cell or a structure advances from an imma-
ture to a mature or specialized state. In the case of
the rat mammary gland, the sequence TEB--AB--1
lobules, marks the process of differentiation. The
Cell Distribution Post DMBA
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FIGURE 4. Effect of DMBA on the distribution of cell population of the TEB and TD of mammary glands. Adapted from Russo,
Tait, and Russo (105).
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FIGURE 5. Incidence of adenocarcinomas and benign lesions in Sprague-Dawley rats treated at different ages with DMBA.
Adapted from Russo, Wilgus and Russo (102) with permission of the editor.
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highest density of TEBs (TEBs/mm2) is found in the
mammary gland of 21-day-old rats and decreases
steadily until the rats reach 63 days of age (101,
102). This decrease is accompanied by the differenti-
ation of this structure into ABs and of these into
lobules. The administration of DMBA to rats of dif-
ferent ages induces tumors with an incidence which
is directly proportional to the density of TEBs
which are ready to differentiate into ABs. The high-
est incidence of carcinomas and number of tumors
per animal is obtained when DMBA is administered
to rats which are 40 and 46 days old, a period when
TEBs are most actively differentiating into ABs
(Fig. 5).
The susceptibility of the mammary gland to carci-
nogenesis decreases significantly with age (102, 106).
This has been explained as a consequence of a dimi-
nution in the number of undifferentiated structures.
The sharp decrease in TEBs/mm2 observed in ani-
mals older than 55 days is also accompanied by a
lower incidence of tumor formation as well as a
lower number of tumors per animal with increasing
age (101, 102). ABs which are more differentiated
structures are the site of origin of benign lesions,
the number of which increases with aging as a con-
sequence of the greater density of ABs present in
the gland when DMBA is administered at older
ages (Fig. 5) (101, 102).
Mammary tumorigenesis by carcinogens is also
inhibited in rats in which mammary growth has
been prestimulated by hypothalamic lesions (107), or
pituitary grafting (108) or when the carcinogen is
administered to lactating rats (89). Decreased tumor
incidence has also been observed when mice (109)
and rats (90, 106, 110) are inoculated with chemical
carcinogens after pregnancy and lactation. The pro-
tective effect of pregnancy and lactation that ex-
tends to the postweaning period has been attrib-
uted to the higher degree of differentiation of the
mammary gland (101). This protective effect is mani-
fested by a significantly low incidence of carcinomas
developed by parous rats when a single dose of
DMBA is administered after the glands have re-
gressed to a resting stage (Table 2). This indicates
that it is not the hormonal status of pregnancy and
lactation that protect the gland, but the permanent
changes induced in the gland structure and in the
biological properties of the gland epithelium which
are independent of the hormonal status of the host
(111). In order to be protective pregnancy must be
completed. Pregnancy interruption slightly in-
creases the incidence of carcinomas, and this is re-
lated to an incomplete differentiation of the gland
(Fig. 6) (112).
Susceptibility of the Mammary
Gland to Carcinogenesis as a
Function of Differentiation and
Cell Kinetics
The degree of differentiation of the mammary
gland can be described at a given time in the life
span of the rat according to the number of TEBs,
TDs, ABs and lobules. A decrease in the density of
TEBs is observed with aging, and in the glands of
parous rats, TEBs are undetectable (101, 102, 106).
The high susceptibility of TEBs to carcinogenesis is
the result of certain characteristics of its epithe-
lium, mainly a high proliferative activity, reflected
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FIGURE 6. Incidence of mammary tumors (adenocarcinomas)
in the mammary gland of DMBA-treated rats. Adapted
from Russo and Russo (112) with permission of the editor.
Table 2. Tumor incidence and tumor types developed in rat mammary glands after DMBA administration.a
No. of rats
Group with tumor/ Percent of rats Total no. Carcinomas Fibroadenomas Latency
no. of rats with tumor of tumors No. % No. % period, wk.
Young virgin 16/21 76.2 34 34 100 0 0 8-9
Old virgin 14/26 53.8 19 12 63 7 36 11-21
Multiparous 18/51 35.3 19 4 21 15 79 13-19
aData from Russo and Russo (106).
189RUSSO ETAL.
in high mitotic and DNA synthetic indices (Table 3)
(106). The influence of these factors has been sub-
stantiated by determining the length of each one of
the phases of the cell cycle (TC) and the growth frac-
tion (GF) of the epithelium lining the various termi-
nal structures of the mammary gland (113).
The TEB possesses the highest mitotic and DNA
synthetic activities and GF (113), and its epithelium
has a very short T, (Fig.7). The progressive differen-
tiation of TEB to AB and lobule is accompanied by a
diminution in mitotic and DNA synthetic activities
and GF, while T, lengthens, mainly due to lengthen-
ing of the G1 phase (Fig. 7). These changes resulting
from differentiation are observed within a single
gland, but they are accentuated with aging (Fig. 7).
Complete differentiation of the mammary gland
as a consequence of pregnancy and lactation elimi-
nates the undifferentiated structures, resulting in a
concomitant decrease in mitotic and DNA labeling
indices, GF and further lengthening of T, (113). No
variations in the length of S phase are observed
either with aging or parity or for the different com-
partments of the gland. Pregnancy, therefore, in-
duces two basic changes in cell kinetic parameters
in the mammary gland: one is the increase in the
size of the nonproliferative compartment (G.), and
the second is the lengthening of G1 phase of the cell
cycle (Fig. 7) (113). These cell kinetic changes could
explain the refractoriness of the mammary gland to
DMBA-induced carcinogenesis. That is, due to the
Table 3. Percentage of TEB, TD and AB-containing labeled cells and percentage of labeled cells in these structures.a
TEB TD AB
Group % labeled °/ labeled % labeled % labeled % labeled % labeled
cellsb TEB cellsb TD cellsb AB
Young virgin 34.4 + 7.6 100 12.3 + 5.8 70 7.9 + 3.3 50
Old virgin 14.8 + 4.7 100 4.9 + 3.4 28 10.9 + 1.7 5
Multiparous 0.0 0 0.3 + 0.5 8.2 0.3± 0.05 0.9
aData from Russo and Russo (106).
bValues are means ± SD of the DNA labeling indexes at the moment of DMBA administration.
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effect of pregnancy on differentiation of the mam-
mary gland, TEBs and TDs shift all their cells to
the formation of ABs and lobules. When the lobular
structures regress from their functional activity,
the cells present in the postpregnancy and/or post-
lactational state have entered Go or a quiescent
state. If the cells are treated at this point in vivo
with a carcinogen, they are refractory to carcinoma
development (106) and in vitro are less susceptible
to the effects of DMBA (114, 115).
Endocrinological Milieu and
Susceptibility of the Rat Mammary
Gland to Carcinogenesis
Since the mammary gland is under hormonal con-
trol (116) and the reproductive history affects the
risk of mammary cancer, interest has been gener-
ated toward the study of the endocrinological status
of rats with different susceptibility to carcinogene-
sis. Previous reports have shown variations in hor-
monal levels in different strains of rats and mice
with varying incidence of mammary tumors (117-
120). However, when rats of the same strain but
with different susceptibility to carcinogenesis be-
cause of variations in age and in reproductive his-
tory are compared, it is found that such differences
in susceptibility are not related to prolactin (PRL)
or estrogen levels at the time of, or after DMBA ad-
ministration (Figs. 8-10) (121, 122). Several changes
have been observed in young virgin (YV), old virgin
(OV) and parous (P) rats after DMBA administra-
tion; the most conspicuous are: hyperplasia of pitui-
tary PRL cells, high serum PRL levels, nodular hy-
perplasia of the adrenal cortex, high serum estra-
diol levels, and lack of adrenal necrosis in all parous
rats and in some old virgin rats.
Notwithstanding the modifications in the hormon-
al milieu observed in susceptible and nonsusceptible
rats after DMBA administration, there is not a clear
correlation between the hormonal changes induced
and the degree of susceptibility of the mammary
gland to carcinogenesis, since parous rats that re-
ceived the inducer (DMBA) and have the same endo-
crinological milieu as young and old virgin rats do
not develop tumors. This supports the importance
of the degree of the mammary gland differentiation
at the moment of carcinogen administration as a
main factor in the different susceptibility of the
gland to carcinogenesis (101, 113).
In Vitro Study of Mammary Gland
Susceptibility to Carcinogenesis
The methods used for culture and the character-
ization and identification of mammary epithelial cells
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FIGURE 8. Serum PRL levels (RIA) in YV, OV and P rats
before (basal) and after DMBA or oil administration. The
values were compared with basal levels; statistically
significant differences (*) were considered with p < 0.005.
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before (basal) and after DMBA or oil administration. The
values were compared with basal levels; statistically
significant differences (*) were considered with p < 0.005.
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have been described (115, 123, 124). Differences in
the growth pattern of mammary gland epithelial
cells in vitro correlate with the observed cell kinetic
variations related to the degree of differentiation of
the gland. Epithelial cells from the mammary gland
of young virgin rats adapt to the culture conditions
rapidly, acting as if the cells were in the logarithmic
phase of growth prior to plating. The cells from old
virgin and parous rats, on the other hand, require a
certain time during which the proliferating cells
adapt to the culture condition, as evidenced by the
presence of a lag phase of cell growth (Table 4). The
number of proliferating cells decreases with age
and parity, as evidenced by peak DNA synthetic ac-
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FIGURE 10. Serum estradiol levels (RIA) in YV, OV and P
rats before (basal) and after DMBA or oil administration.
The values were compared with basal levels; significant
differences (*) were considered with p < 0.005.
tivity. This means that even when normal growth
restraints are removed as the cells are cultured in
vitro, only certain cells in the population are able to
proliferate, which implies that the differences are
intrinsic to the epithelial cells and not to host fac-
tors (114).
An important difference in the growth curve of
young virgin, old virgin and parous rat mammary
cells is that the lag phase is lengthened in the two
latter groups, which correlates with observations in
vivo (113, 126). This initial resting state observed in
old virgin and parous rat mammary gland primary
cultures results in a lower DMBA-DNA binding
(115) and acts as a protective mechanism against the
toxic effect of DMBA when the carcinogen is added
immediately after plating, which is more pro-
nounced on the cells of young virgin rats (123, 124).
DMBA added to cells at the peak of DNA synthesis
induces a greater growth inhibition at lower doses
than when the carcinogen is added during the first
phase of growth. These observations confirm that
cultured cells are generally more sensitive if the
carcinogen is added at a time when the cells are ac-
tively growing and synthesizing DNA (12&132).
Metabolic Activation of DMBA
In common with other PAHs, the mutagenic and
carcinogenic activities of DMBA are dependent on
its conversion by the P-450/P1-450 monooxygenase
enzyme systems to chemically reactive electrophilic
carbonium ions which will react covalently with crit-
ical cellular macromolecules especially DNA within
the target tissue (133-135). This latter process is
now considered to be the most probable initiation
event in malignant transformation (133-137). Differ-
ences in susceptibility to DMBA have been ob-
served between virgin and parous rats. This raises
the possibility that hormones resulting from the
Table 4. Effect of degree of susceptibility.
Mammary gland degree of susceptibility
Parameters of susceptibility High Intermediate Low Reference
Morphological differentiation, cell kinetics TEB>TD>AB>LOB TEB<TD>AB>LOB TD<AB<LOB (62, 99, 101, 102, 110)
MI 7.03 ± 1.00 2.90 ± 2.30 0.09 ± 0.16 (62, 83)
DNA-LI 34.40 ± 7.60 14.80 ± 4.70 0.30 ± 0.50 (83, 110, 113)
Tc 9.93 ± 0.31 18.75 ± 0.99 49.63 ± 6.86 (113)
G.F. 0.55 0.19 0.0097 (113)
Lag phase in culture, hr None 24 36 (123, 124)
No. of doublings in culture 3.04 ± 0.3 3.00 ± 0.14 1.50 ± 0.18 (123, 124)
3H-DMBA uptake, grains/nucleus 6.80 ± 2.60 1.30 ± 0.80 0.70 ± 0.50
DMBA-DNA binding,pmole/mole DNA-P 33 25 20 (115)
DNA repair
UDS, % of cells 20.0 ± 2.8 37.3 ± 3.0 62.5 ± 3.0 (128)
Adduct removal at 24 hr, % 15 7 25 (125)
Carcinoma development High Intermediate Low to none (83, 101)
Benign lesion development Intermediate High Low to none (83, 101)
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pregnancy and ensuing lactation could have modi-
fied the mammary epithelial cells in their ability to
metabolize DMBA to its carcinogenic species, their
ability to bind DMBA to DNA and to repair the re-
sulting DMBA-induced DNA damage.
DMBA-DNA Binding by Rat Mammary
Epithelium
After administration of DMBA to rats in vivo it
binds to the DNA of mammary parenchymal cells
with a ratio proportional to the rate of cell prolifera-
tion (138-140). It has been demonstrated that a cor-
relation exists between the rats' age and level of
DNA synthesis, which in turn is related to the
amount of DMBA specifically bound to mammary
gland DNA and the susceptibility of the gland to
carcinogenesis (138-140). However, the observed dif-
ferences in DMBA-DNA binding are due not only to
age but also to the reproductive history of the rat,
since there are differences in the amount of DMBA
bound to the DNA of mammary epithelial cells de-
rived from virgin and parous rats. It has been
observed in vitro that at all time points, the high-
est level of DMBA binding occurs in young virgin
cells, suggesting that they are more susceptible
to the effects of increasing amounts of DMBA (115).
The largest difference in terms of binding, however,
are obtained in 24-hr cultures where binding in
young virgin cells is 20-30% higher than in old vir-
gin cells and 35-40% higher than parous cells over a
dose range of 0.1-0.4 ,ug DMBA/mL. This correlates
well with the fact that, at 24 hr, both old virgin and
parous cells are still in a resting phase, whereas
young virgin cells are already in their logarithmic
phase of growth (124). This lower binding of DMBA
during the lag phase of old virgin and parous cells
in vitro, therefore, implies that both the small
growth fraction and proliferative compartment in
both groups of animals (106) are important factors in
determining the eventual carcinogenic response by
reducing the capacity of their cells to bind DMBA.
Therefore, young virgin rats, whose mammary
glands contain numerous TEBs with a high prolifer-
ative activity show the highest uptake of 3H-DMBA
into mammary parenchymal cells in vivo as deter-
mined by autoradiographic techniques (Table 5).
Uptake into TEB epithelium occurs selectively in
the nucleus. More differentiated structures, such as
ABs, which are the predominant structures in par-
ous rat mammary gland, are characterized by hav-
ing a low DNA synthetic activity and mitotic index,
both of which are associated with a low DMBA up-
take (106) and with a low DMBA-DNA binding in vi-
tro (115). The significance of these results, therefore,
lies in the relationship between the high nuclear up-
take and the higher DNA synthetic activity in the
TEBs (Table 6) and the fact that TEBs are the site
of origin of mammary carcinomas (Table 6) (Fig. 3).
Identification of DMBA-DNA Adducts in Rat
Mammary Gland
Identification of DMBA-DNA adducts in the
mammary gland with the use of the Sephadex LH-
20 chromatographic method developed by Baird and
Brookes (141) reveals that the elution volumes of
the DMBA-nucleic acid adduct peaks derived from
young virgin, old virgin and parous cells are identi-
cal, suggesting that cells from the three groups of
rats treated with DMBA in vitro generate similar
adducts (125) (Fig. 11). These results are in agree-
ment with those reported for the major DMBA-
nucleic acid adducts generated in mouse skin (142),
rodent embryo cells in culture (143, 144) and in
human mammary epithelial cells (145) treated with
DMBA. Although our results are consistent with
the bay-region theory of polycyclic hydrocarbon
carcinogenesis (146) and provide evidence that
Table 6. Correlation between the uptake of 3H-DMBA and the
DNA-LI in the different compartments of the mammary gland.a
Structure Grain/nucleus DNA-LI
1 TEB 6.8 ± 2.6 34.4 ± 7.6
2 TD + ducts 1.3± 0.8 12.3± 5.8
3 AB 0.7±0.5 7.9±3.3
aStudent's t-tests were done. The following comparisons
were significantly different: grains/nucleus, 1 vs. 2, p<0.01, 1
vs. 3, p<0.001; DNA-LI, 1 vs. 2, p<0.01, 1 vs. 3, p<0.001, 2 vs.
3, p<0.05.
Table 5. Autoradiography of incorporation of 3H-7,12-dimethylbenz(a)anthracene into the rat mammary gland.a
No. of Grains/ Grains/ Grains/ Grains/
Structure cells cell nucleus cytoplasm lumen
1 TEB 740 9.7 ± 2.9 6.8 ± 2.6 2.7 ± 0.9 0.97 ± 0.2
2 TD + Ducts 592 2.1 ± 1.4 1.3 ± 0.8 0.8 ± 0.6 0.98 ± 0.6
3 AB 345 1.0 ± 0.7 0.7 ± 0.5 0.5 ± 0.3 0.40 ± 0.3
aStudent's t-tests were done. The following comparisons were significantly different: grains/cell, 1 vs. 2, p<0.01, 1 vs. 3,
p<0.001; grains/nucleus, 1 vs. 2, p<0.001, 1 vs. 3, p<0.001; grains/cytoplasm, 1 vs. 2, p<0.01, 1 vs. 3, p<0.01. Labeled DMBA (3H-
DMBA, lmCi) with 20 mg cold DMBA as a carrier was dissolved in 1 mL sesame oil and given IG to 55-day-old virgin rats. After
24 hr, the mammary glands were removed, fixed in Bouin's and processed for light microscopy. Paraffin sections were coated
with NTB-2 Kodak emulsion and processed for autoradiography.
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FIGURE 11. Elution profiles from Sephadex LH-20 columns of
hydrolysates of DNA isolated from YV, P and OV rat
mammary epithelial cells exposed to 0.5 tAg 3H-DMBA/mL
for 24 hr; (Arrow) the position of elution of the added UV
marker of 4-(p-nitrobenzyl)pyridine. Reprinted with per-
mission of the editors from Tay and Russo (125).
DMBA-3,4-dihydrodiol-1,2-oxide is involved in the ac-
tivation and binding of DMBA to DNA in mammary
epithelial cells, the fact that adducts derived from
virgin and parous rats, which are known to have dif-
ferent susceptibility to DMBA-induced mammary
carcinogenesis, are identical, indicates that the sus-
ceptibility of the gland depends upon factors unre-
lated to the generation of different DNA adducts. It
does not, however, rule out the possibility that the
different susceptibility may be due to quantitative
differences, since we have already demonstrated
that the overall level of binding is different between
virgin and parous rat mammary epithelial cell,
treated with DMBA in vitro (115).
DNA Repair by Rat Mammary Epithelium
in Primary Culture
Carcinogen-induced DNA lesions are subject to
repair by various mechanisms. Since repair of dam-
aged DNA in mammalian cells appears to be an im-
portant process with regard to cell susceptibility
and cell death, the ability of cells to repair damaged
DNA will therefore determine the end biological re-
sult of the DNA-carcinogen interaction (125, 147-
153). Since parous rats are refractory to the carcino-
genic effect of DMBA, it has been postulated that
their mammary gland epithelium must repair more
efficiently the DMBA induced DNA damage.
The irnduction of unscheduled DNA synthesis
(UDS) in 48-hr cultures of rat mammary epithelial
cells following exposure to DMBA, measured by 3H-
thymidine incorporation into the nucleus of cells in
the presence of hydroxyurea, indicates that induc-
tion of UDS is proportional to the dose of DMBA be-
tween 0.1 and 1.0 ,ug/mL. Induction of UDS is 2- to 4-
fold higher in parous cells than in old virgin and
young virgin cells, indicating a more efficient DNA
repair process by cells of the parous rat mammary
epithelium (Fig. 12).
Determination of DNA repair by measuring the
efficiency of removal of DMBA adducts (125) follow-
ing the protocol of Dipple and Hayes (154) reveals
that in both young virgin and old virgin cells, the
excision of adducts is very slow. For young virgin
4YV) cells, the values show that at 5 and 18 hr, the
quantitative measure of the excision of DMBA-DNA
adducts obtained by calculating the time-dependent
decrease in specific radioactivity of the less dense
DNA peak following centrifugation on alkaline cesi-
um chloride density gradients reveals that only 3%
and 9% of the initial adducts are removed, increas-
ing to only 24% at 48 hr. In old virgin cells, no loss
of specific activity is detected within the first 18 hr,
and the total loss of adducts after 48 hr is only 12%
of the initial amount bound. Cells of parous rats, on
the other hand, show an 8% loss of specific activity
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FIGURE 12. Induction of unscheduled DNA synthesis in vitro
in YV, OV and P rat mammary epithelial cells exposed to
DMBA for 24 hr.
within 5 hr. This loss steadily increases up to 38%
by 48 hr. When the relationship between the
amount of adducts excised at 24 and 48 hr is plotted
against the initial extent of binding (Fig. 13), the re-
sults demonstrate that parous cells are capable of a
greater and more rapid rate of adduct removal than
either old virgin or young virgin cells. Thus, the low
tumor incidence observed in parous rats may be
due not only to a low DMBA-DNA binding, but also
to more efficient DNA repair processes which may
have arisen as the result of the cellular differentia-
tion induced in the mammary epithelium by preg-
nancy and lactation.
Conclusions
The results described above indicate that suscep-
tibility of the mammary gland to carcinogenesis is a
composite of multifactorial aspects centered in the
differentiation of the gland. The degree of differen-
tiation of the gland as determined by morphological
development, cell kinetics parameters and behavior
in culture determines the affinity of the target to
carcinogen-binding to DNA and the extent and pro-
ficiency in repair of damaged-DNA. Based upon
these parameters it is possible to classify the sus-
ceptibility of the mammary gland to carcinogenesis
as high, intermediate and low (Table 4). Thus mea!
surement of one or more of these parameters can in-
dicate the degree of susceptibility of a given mam-
mary tissue to carcinogenesis. Preliminary results
in our laboratory suggest that a correlation be-
tween human breast tissue and rat mammary gland
findings is possible. (155, 156).
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